NASDAQ:CME - Nasdaq - US12572Q1058 - Common Stock - Currency: USD
Taking everything into account, CME scores 5 out of 10 in our fundamental rating. CME was compared to 227 industry peers in the Capital Markets industry. While CME has a great profitability rating, there are some minor concerns on its financial health. CME is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 2.53% | ||
ROE | 13.14% | ||
ROIC | 17.71% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 78.46% | ||
PM (TTM) | 34.1% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.1 | ||
Debt/FCF | 0.97 | ||
Altman-Z | 0.83 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.01 | ||
Quick Ratio | 1.01 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.37 | ||
Fwd PE | 23.5 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 26.09 | ||
EV/EBITDA | 11.38 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.79% |
260.33
-2.2 (-0.84%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.79% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.37 | ||
Fwd PE | 23.5 | ||
P/S | 9.19 | ||
P/FCF | 26.09 | ||
P/OCF | 25.42 | ||
P/B | 3.54 | ||
P/tB | N/A | ||
EV/EBITDA | 11.38 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 2.53% | ||
ROE | 13.14% | ||
ROCE | 22.8% | ||
ROIC | 17.71% | ||
ROICexc | 19.36% | ||
ROICexgc | 378.45% | ||
OM | 78.46% | ||
PM (TTM) | 34.1% | ||
GM | N/A | ||
FCFM | 35.23% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.1 | ||
Debt/FCF | 0.97 | ||
Debt/EBITDA | 0.33 | ||
Cap/Depr | 27.91% | ||
Cap/Sales | 0.92% | ||
Interest Coverage | 61.67 | ||
Cash Conversion | 44.21% | ||
Profit Quality | 103.3% | ||
Current Ratio | 1.01 | ||
Quick Ratio | 1.01 | ||
Altman-Z | 0.83 |